Should We Use Oral Valacyclovir in Acute Herpetic Gingivostomatitis in Children?
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
Primary herpetic gingivostomatitis is a frequent problem in pediatrics. Complications of this
are dehydration, pain and hospitalisation. The objective of this randomized controlled trial
is to assess the clinical efficacy of oral Valacyclovir to decrease the duration of symptoms
associated with acute herpes gingivostomatitis in children. This study will involve 80
children aged 1 to 8 years old to receive weight adjusted doses of valacyclovir for 7 days.
The primary outcome measure will be the duration (in days) of feeding and/or drinking
difficulties.